{"gene":"P2RY4","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":1996,"finding":"Human P2Y4 receptor, stably expressed in 1321N1 astrocytoma cells, functions as a pyrimidinergic GPCR that couples to phospholipase C to produce inositol trisphosphates. UTP is the primary full agonist; ATP acts as a pure antagonist at early times and partial agonist later. Pertussis toxin inhibited the early UTP response (~62%), suggesting the receptor can couple to both Gi/o and Gq proteins in a time-dependent manner.","method":"Stable transfection in 1321N1 cells; inositol phosphate accumulation assay; pertussis toxin treatment","journal":"European journal of pharmacology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct functional reconstitution in transfected cells with pharmacological dissection; multiple orthogonal methods (IP accumulation, PTX block); replicated across multiple labs","pmids":["8997625"],"is_preprint":false},{"year":1996,"finding":"Human P2Y4 receptor (cloned as P2P) is encoded by an intronless single-copy gene, expressed predominantly in pancreas, and encodes a 365 amino acid GPCR with high structural homology to P2U/P2Y purinoceptors within transmembrane domains.","method":"Genomic cloning, Northern blot, RT-PCR tissue distribution","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — original cloning with functional domain characterization; single lab but molecular and expression data orthogonal","pmids":["8617367"],"is_preprint":false},{"year":1996,"finding":"Human P2Y4 receptor is not antagonized by suramin or PPADS (unlike P2Y1 and P2Y2), defining a pharmacologically distinct profile among cloned P2Y receptors when stably expressed in 1321N1 cells.","method":"Stable transfection in 1321N1 cells; pharmacological antagonism assays","journal":"British journal of pharmacology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct functional reconstitution; replicated across multiple independent labs","pmids":["8968535"],"is_preprint":false},{"year":1998,"finding":"Rat P2Y4 receptor (rP2Y4), unlike the human ortholog, is activated equipotently by both ATP and UTP (partial agonists: ADP, ATPγS, 2-MeSATP, UDP), making it pharmacologically similar to the P2U receptor subtype but suramin-insensitive (distinguishing it from P2Y2). The receptor is reversibly antagonized by Reactive Blue 2.","method":"Rat genomic library cloning; expression and pharmacological characterization in transfected cells","journal":"British journal of pharmacology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct cloning and functional reconstitution; replicated by independent lab (Webb et al. 1998)","pmids":["9647463","9751165"],"is_preprint":false},{"year":1998,"finding":"P2Y4 receptor mediates phospholipase C responses to extracellular UTP and ATP in spontaneously hypertensive rat aortic smooth muscle cells. ATP behaves as a partial agonist compared to UTP; UDP response is abolished by hexokinase, consistent with conversion to UTP. P2Y4 mRNA was confirmed by RT-PCR in these cells. Stimulation activates p42/p44 MAPK, which in turn drives thymidine incorporation (proliferation).","method":"RT-PCR; PLC assay; hexokinase competition; MAPK phosphorylation assay; [3H]-thymidine incorporation; comparison with 1321N1 cells transfected with hP2Y4","journal":"British journal of pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal functional assays in native cells confirmed by transfected cell comparison; single lab","pmids":["9690862"],"is_preprint":false},{"year":2000,"finding":"ATP is a competitive antagonist (pA2 = 6.15) at the human P2Y4 receptor but a potent full agonist at the rat P2Y4 receptor, demonstrating a species-specific difference in agonist/antagonist behavior at this receptor. CTP and Ap4A were partial antagonists at hP2Y4.","method":"Stable expression in 1321N1 cells; intracellular Ca2+ measurement under conditions minimizing nucleotide metabolism; Schild plot analysis","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1 / Strong — rigorous pharmacological reconstitution with Schild analysis; confirmed species pharmacology difference; replicated by Herold et al. 2003","pmids":["10779375"],"is_preprint":false},{"year":2000,"finding":"P2Y4 receptor (along with P2Y1, P2Y2, P2Y6) couples to RhoA activation and subsequent Rho kinase-dependent actin stress fiber formation in vascular myocytes. Dominant-negative RhoA and C3 exoenzyme blocked this response. Transfection of P2Y4 into Swiss 3T3 cells confirmed Rho kinase-dependent actin reorganization.","method":"Dominant-negative RhoA transfection; C3 exoenzyme treatment; Y-27632 Rho kinase inhibition; membrane-bound RhoA quantitation; Swiss 3T3 cell transfection","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (genetic dominant negative, bacterial toxin, pharmacological inhibitor); single lab","pmids":["10843869"],"is_preprint":false},{"year":2000,"finding":"Agonist-promoted phosphorylation of human P2Y4 receptor at Ser-333 and Ser-334 in the carboxyl terminus mediates UTP-dependent desensitization and internalization (50% loss of surface receptors). Truncation and point mutagenesis identified these residues as essential; the P2Y4-332 truncation mutant showed no UTP-promoted [32P] phosphorylation. In contrast, P2Y6 receptor does not undergo rapid agonist-dependent desensitization or internalization.","method":"Mutagenesis (truncation and point mutations); [32P]Pi radiolabeling; surface receptor quantitation; inositol phosphate desensitization assay in 1321N1 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis combined with radiolabeling and functional assay; multiple mutants tested; rigorous mechanistic dissection in single study","pmids":["11114308"],"is_preprint":false},{"year":2001,"finding":"Mouse P2Y4 receptor is equally activated by UTP and ATP (like rat P2Y4), is antagonized by PPADS and Reactive Blue 2, and is not blocked by suramin — confirming the rodent P2Y4 pharmacological profile. mRNA detected in liver, intestine, stomach, bladder, and lung.","method":"Mouse genomic library screening; stable expression in 1321N1 cells; pharmacological characterization","journal":"European journal of pharmacology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — functional reconstitution in transfected cells; single lab; confirms rodent species pharmacology","pmids":["11290369"],"is_preprint":false},{"year":2001,"finding":"P2Y4 receptor at the apical membrane of vestibular dark cell epithelium mediates inhibition of K+ secretion (electrogenic short-circuit current) by UTP, ATP, and diadenosine tetraphosphate but not UDP. Insensitivity to suramin (100 µM) supports P2Y4 identity. The response showed no desensitization over 15 min of sustained agonist exposure.","method":"Voltage-sensitive vibrating probe (electrophysiology); RT-PCR for P2Y2/P2Y4; pharmacological profiling with antagonists","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct electrophysiological measurement in native epithelium combined with molecular identification; single lab","pmids":["11401851"],"is_preprint":false},{"year":2002,"finding":"P2Y4 receptor protein is immunolocalized specifically to the apical membrane of strial marginal cells and vestibular dark cells in the gerbil inner ear, while P2Y2 is located basolaterally. Western blot detected a 55 kDa band in stria vascularis for P2Y4.","method":"Western blot; fluorescence confocal immunohistochemistry; peptide blocking controls","journal":"The Journal of membrane biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct subcellular localization by confocal microscopy with peptide-blocked controls; single lab","pmids":["11891569"],"is_preprint":false},{"year":2003,"finding":"P2Y4-null mice generated by gene targeting completely lack UTP- and ATP-induced chloride secretion in the jejunum (measured as short-circuit current in Ussing chambers), demonstrating that P2Y4 is required for nucleotide-regulated epithelial chloride transport in the small intestine.","method":"Gene targeting knockout; Ussing chamber short-circuit current measurement; RT-PCR confirmation of mRNA loss","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic knockout with quantitative functional readout; replicated and extended in subsequent knockout studies","pmids":["12644577"],"is_preprint":false},{"year":2003,"finding":"The second extracellular loop (EL2) and NH2-terminus of P2Y4 receptor together form a functional motif determining whether ATP acts as an agonist or antagonist. Chimeric receptor analysis and mutagenesis identified three specific residues in EL2 (Asn-177, Ile-183, Leu-190 in hP2Y4) as key determinants of ATP agonism. Replacement of hP2Y4 EL2 with rP2Y4 EL2 converted ATP from antagonist to near-full agonist.","method":"Human/rat P2Y4 chimeric receptor expression in 1321N1 cells; point mutagenesis; intracellular Ca2+ assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic chimeric and point mutagenesis with functional reconstitution; multiple constructs; rigorous mechanistic dissection","pmids":["14670966"],"is_preprint":false},{"year":2003,"finding":"Human and rat P2Y4 receptors, expressed in rat sympathetic neurons, couple to M-type K+ channels (IC50 ~21–28 nM for UTP) and to N-type Ca2+ channels (IC50 ~273 nM). Ca2+ channel inhibition requires a diffusible intracellular factor lost in ruptured-patch recording and involves Gβγ subunits of Gi/o proteins (blocked by pertussis toxin and transducin Gα). M-current inhibition is PTX-insensitive. P2Y4 couples more effectively to M-type K+ channels than to Ca2+ channels.","method":"Nuclear injection of P2Y4 cDNA into rat sympathetic neurons; whole-cell and perforated-patch electrophysiology; PTX pretreatment; transducin Gα co-expression","journal":"British journal of pharmacology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct electrophysiological reconstitution in neurons with genetic and pharmacological dissection of G-protein coupling; multiple orthogonal methods","pmids":["12540532"],"is_preprint":false},{"year":2003,"finding":"P2Y4 receptor forms homo-dimers and higher-order oligomeric complexes, at least partially assembled through disulfide bonds. Co-transfection with differentially tagged P2Y4 constructs followed by differential co-immunoprecipitation directly demonstrated homodimerization.","method":"Co-transfection with differentially tagged receptors; co-immunoprecipitation; SDS-PAGE under reducing/non-reducing conditions","journal":"Purinergic signalling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-immunoprecipitation with tagged constructs; single lab; confirmed in follow-up study","pmids":["18404459"],"is_preprint":false},{"year":2004,"finding":"Co-localization of P2Y4 and NMDAR1 receptors at the membrane was demonstrated by confocal double immunofluorescence and confirmed by co-immunoprecipitation in cerebellar granule neurons and HEK-293 cells. During hypoglycemia, P2Y4 expression is induced while NMDAR1 is inhibited; both P2 and NMDA antagonists restore basal expression levels.","method":"Co-immunoprecipitation; confocal double immunofluorescence; Western blot during glucose deprivation","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-immunoprecipitation in both native and heterologous cells plus immunofluorescence co-localization; single lab","pmids":["15383322"],"is_preprint":false},{"year":2005,"finding":"P2Y4 receptor activation by UTP in neuroblastoma SH-SY5Y cells facilitates neuritogenesis (detected by morphological analysis and neurofilament NFL immunostaining), increases transcription of differentiation-linked genes (cdk-5, NeuroD6) and activates AP-1 family transcription factors (c-fos, fos-B, jun-D). Prolonged P2Y4 activation also induces cell death.","method":"Transient transfection; morphological phase contrast and confocal microscopy; RT-PCR for immediate-early genes; cytofluorimetric DNA damage assay; AP-1 reporter assays","journal":"Neurobiology of disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal functional readouts after P2Y4 transfection and UTP stimulation; single lab","pmids":["15649700"],"is_preprint":false},{"year":2005,"finding":"Both P2Y2 and P2Y4 receptors present on the luminal membrane of mouse distal colonic mucosa mediate K+ secretion (measured as transepithelial voltage change and blocked by Ba2+ and iberiotoxin). In P2Y2 KO and P2Y4 KO mice the UTP-stimulated K+ secretion was each significantly reduced; in P2Y2/P2Y4 double KO mice it was completely abolished.","method":"P2Y2-null and P2Y4-null and double-knockout mice; Ussing chamber electrophysiology; Ba2+ and iberiotoxin (BK channel) blockers; RT-PCR of isolated crypts","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with double knockout providing complete pathway dissection; direct functional readout in native tissue","pmids":["15718265"],"is_preprint":false},{"year":2005,"finding":"P2Y4 receptor at the apical membrane of gerbil strial marginal cells mediates UTP/ATP-induced decrease in K+ secretion via PLC activation and biphasic intracellular Ca2+ elevation (partially blocked by 2-APB, an IP3R/SOC inhibitor). Suramin (100 µM) was without effect, consistent with P2Y4 identity.","method":"Short-circuit current measurement with voltage-sensitive probe; intracellular Ca2+ imaging; 2-APB pharmacology; RT-PCR for P2Y subtypes","journal":"Cell communication and signaling : CCS","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct electrophysiology combined with Ca2+ imaging and molecular identification; single lab","pmids":["16266433"],"is_preprint":false},{"year":2005,"finding":"P2Y4 receptor (not P2Y2) fully mediates chloride secretory response to UTP in mouse colon (both apical and basolateral sides) and in jejunum (apical side). P2Y4-null mice showed abolished colonic chloride secretion to UTP, whereas P2Y2-null mice were unaffected in the colon. The UTP-potentiated forskolin response was also abolished in P2Y4-null jejunum.","method":"P2Y2-null and P2Y4-null knockout mice; Ussing chamber short-circuit current; chloride-free medium control; amiloride/phloridzin controls","journal":"British journal of pharmacology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout comparison of two receptor subtypes with multiple conditions; extends and confirms PMID 12644577","pmids":["16056234"],"is_preprint":false},{"year":2005,"finding":"P2Y4 receptor co-expressed with BK channels in Xenopus oocytes leads to a ~30% increase in BK current upon UTP stimulation, while P2Y2 co-expressed with BK channels causes ~20% inhibition. Co-expression of P2Y4 with IK channels produces a large 22-fold UTP-stimulated current activation. This demonstrates differential regulation of Ca2+-activated K+ channels by P2Y4 vs P2Y2 subtypes.","method":"Xenopus oocyte co-expression; electrophysiological recording of K+ channel activity; UTP stimulation","journal":"Pflugers Archiv : European journal of physiology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct reconstitution in oocyte expression system; two K+ channel types tested; single lab","pmids":["16075244"],"is_preprint":false},{"year":2007,"finding":"In native neuronal cells, P2Y4 receptor forms high-order oligomeric complexes detectable by Blue Native gel electrophoresis. Dimeric P2Y4 selectively partitions into lipid rafts in synaptosomes. UTP stimulation does not shift P2Y4 oligomerization state (in contrast to P2Y6). In naive PC12 cells, endogenous P2Y4 forms hetero-oligomers selectively with P2Y6 (not with P2Y1, P2Y2, or P2Y11).","method":"Blue Native gel electrophoresis; co-immunoprecipitation; lipid raft fractionation from synaptosomes; co-transfection studies","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — BN-PAGE and co-immunoprecipitation with subcellular fractionation; orthogonal methods; single lab","pmids":["17481575"],"is_preprint":false},{"year":2008,"finding":"ATP stimulates excitability of guinea pig gallbladder smooth muscle via P2Y4 receptors (RT-PCR confirmed P2Y4 but not P2Y2 expression in muscularis). This excitation requires COX-1 activity (blocked by indomethacin and SC-560) but not COX-2, indicating P2Y4 stimulates prostanoid production via COX-1 to increase smooth muscle excitability.","method":"Intracellular recording (membrane potential and action potential frequency); RT-PCR; pharmacological inhibitors (suramin, PPADS, indomethacin, SC-560, nimesulide)","journal":"American journal of physiology. Gastrointestinal and liver physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — electrophysiology combined with molecular identification and pharmacological pathway dissection; single lab","pmids":["18436624"],"is_preprint":false},{"year":2009,"finding":"ATP modulates ERK1/2, p38, and JNK1 MAPKs and transcription factors (ATF-1, c-Fos, c-Jun, Jun D) via P2Y2 and P2Y4 receptors in MCF-7 breast cancer cells through a PKC-dependent (not Src-dependent) pathway for MAPK activation. PKC and Src both contribute to c-Fos induction and ATF-1 phosphorylation.","method":"RT-PCR receptor identification; specific kinase inhibitors; Src antisense oligonucleotides; Western blot for phospho-MAPKs and transcription factors","journal":"Archives of biochemistry and biophysics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — pharmacological inhibitors without receptor-specific knockdown; cannot fully separate P2Y2 from P2Y4 contribution; single lab","pmids":["19900397"],"is_preprint":false},{"year":2010,"finding":"P2Y4 receptor at the apical membrane of Reissner's membrane epithelium mediates UTP-induced inhibition of amiloride-sensitive Na+ absorption (ENaC) via PLC activation and reduction of plasma membrane PIP2 (not through PKC or store-operated channels). PLC inhibitors markedly reduced the effect; the P2Y4 subtype identity was confirmed by suramin/PPADS insensitivity and RB-2 sensitivity.","method":"Voltage-sensitive vibrating probe; amiloride short-circuit current; PLC inhibitors (U73122, ET-18-OCH3); PKC modulators; 2-APB; immunohistochemistry","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct electrophysiology with pharmacological pathway dissection in native epithelium; multiple inhibitors tested; single lab","pmids":["20220010"],"is_preprint":false},{"year":2012,"finding":"P2Y4 receptor is expressed in cardiac endothelial cells but not cardiomyocytes. P2Y4-null mice display microcardia due to reduced endothelial cell proliferation, migration, and PDGF-B secretion in response to UTP. Microvessel and cardiomyocyte proliferation is reduced early postnatally in P2Y4-null hearts, establishing P2Y4 as a regulator of postnatal cardiac growth through endothelial-cardiomyocyte interactions.","method":"P2Y4-null mice; cardiac endothelial cell isolation; proliferation and migration assays; PDGF-B secretion measurement; histological quantitation of cardiomyocyte and microvessel density","journal":"Angiogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout with multiple cellular functional assays; single lab; endothelial-cardiomyocyte interaction mechanism proposed and supported","pmids":["22437266"],"is_preprint":false},{"year":2012,"finding":"Apical targeting of P2Y4 receptor to the apical membrane of polarized epithelial cells is directed by a 23 amino acid sequence in the C-terminal cytoplasmic tail. Four hydrophobic residues near the COOH-terminal end are necessary for apical sorting; mutation of these residues results in basolateral enrichment. The signal is autonomous: it can redirect the normally basolateral P2Y12 receptor to the apical membrane.","method":"Mutagenesis (truncation and point mutations); confocal immunofluorescence in polarized MDCK/Caco-2 cells; chimeric P2Y4/P2Y12 receptor constructs","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic mutagenesis with functional localization readout; autonomous signal demonstrated by domain transfer to heterologous receptor; multiple constructs","pmids":["23054062"],"is_preprint":false},{"year":2013,"finding":"P2Y4 receptor mediates ATP-triggered pinocytosis in microglia via the PI3K/Akt signaling cascade. siRNA knockdown of P2Y4 reduced nucleotide-induced pinocytosis. Soluble amyloid-beta 1-42 induced self-uptake in microglia through pinocytosis involving autocrine ATP signaling activating P2Y4 receptors.","method":"P2Y4 siRNA knockdown; pharmacological analysis; PI3K/Akt inhibitors; fluorescence-based pinocytosis assay","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown plus pharmacological pathway dissection with functional readout; single lab","pmids":["24001770"],"is_preprint":false},{"year":2015,"finding":"P2Y4-null mice display smaller myocardial infarcts, reduced neutrophil infiltration, and reduced fibrosis after LAD ligation. Gene profiling identified endothelin-1 (ET-1) as a target gene of P2Y4 in ischemic heart. Loss of P2Y4 is correlated with reduced endothelial cell number, reduced ET-1, reduced MMP-9 and MMP-8 expression, and reduced microvascular hyperpermeability and endothelial adhesion molecule expression.","method":"P2Y4-null mice; LAD ligation model; gene expression profiling; immunohistochemistry for neutrophils; ET-1 measurement; MMP/TIMP expression analysis; LPS-induced inflammation model","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with multiple functional and molecular readouts; ET-1 as mechanistic link supported by correlative evidence; single lab","pmids":["25595790"],"is_preprint":false},{"year":2016,"finding":"P2Y4 receptor expressed in cardiac adipose-derived stem cells acts as a negative regulator of adipogenic differentiation and cardiac fat formation. UTP (P2Y4 ligand) inhibited maturation of differentiated cardiac ASCs and reduced adipogenesis-linked gene expression and adiponectin secretion. P2Y4-null mice had higher cardiac adipose tissue mass and higher adiponectin secretion. Cardioprotection from P2Y4 loss was absent in P2Y4/adiponectin double-KO mice, placing adiponectin downstream of P2Y4 in this pathway.","method":"P2Y4-null mice; adipogenic differentiation assays; gene expression (RT-PCR); adiponectin secretion measurement; double-KO epistasis (P2Y4 x adiponectin); LAD ligation","journal":"Stem cells and development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis (double KO) and functional differentiation assays; adiponectin placed downstream; single lab","pmids":["27855539"],"is_preprint":false},{"year":2016,"finding":"P2Y4 receptor in neural precursors promotes specification of glutamatergic neuron identity. Transient P2Y4 activation during ESC neuronal differentiation increased proportion of neurons expressing vGluT (glutamatergic marker). A subpopulation of adult hippocampal type 2 NSCs expresses P2Y4; its activation induced vGluT and TBR1 expression in descendant neurons. Inhibition of P2Y4 signaling abolished these effects.","method":"Mouse ESC differentiation assay; P2Y4 pharmacological activation/inhibition; immunostaining for vGluT and TBR1; adult hippocampal NSC analysis","journal":"Stem cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological gain- and loss-of-function in both ESC and adult NSC systems; single lab","pmids":["26972684"],"is_preprint":false},{"year":2019,"finding":"HIV-1 Tat protein increases P2Y4 receptor expression in astrocytes. P2Y4 signaling mediates Tat-induced proinflammatory cytokine production via PI3K/Akt and ERK1/2-dependent pathways. siRNA knockdown of P2Y4 reduced cytokine production and relieved Tat-mediated neuronal apoptosis in vitro. In vivo Tat challenge in P2Y4 knockdown mice showed decreased hippocampal inflammation and neuronal damage.","method":"siRNA knockdown; real-time PCR; Western blot; cytometric bead array; TUNEL/MTT assays; in vivo P2Y4 knockdown mouse model; PI3K/Akt/ERK pathway inhibitors","journal":"Journal of neuroinflammation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA KD in vitro and in vivo with pathway inhibitors; multiple orthogonal functional readouts; single lab","pmids":["30947729"],"is_preprint":false},{"year":2019,"finding":"Mutagenesis combined with homology modeling showed that the orthosteric binding site of P2Y4 receptor is more restricted than that of P2Y2. Mutation of Y197 to alanine in P2Y4 receptor conferred gain of ATP sensitivity, identifying this residue as a key determinant of ATP selectivity. Anthraquinone antagonists likely bind orthosteric or allosteric sites depending on their substitution pattern.","method":"Site-directed mutagenesis; receptor homology modeling; docking studies; functional Ca2+ assay in transfected 1321N1 cells","journal":"Biochimica et biophysica acta. General subjects","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — mutagenesis with functional validation and computational modeling; single lab; functional gain-of-function confirms computational prediction","pmids":["31812541"],"is_preprint":false},{"year":2022,"finding":"P2Y4-null mice display anti-inflammatory pericardial adipose tissue changes after myocardial infarction, including adipocyte beiging with increased PD-L1 expression, higher regulatory M2c macrophages and Treg cells. Injection of anti-PD-L1 blocking antibody abolished the reduction in T cell infiltration and cardiac fibrosis in P2Y4-null ischemic mice, placing PD-L1 downstream of P2Y4 loss in cardioprotection.","method":"P2Y4-null mice; LAD ligation; flow cytometry (M2c macrophages, Tregs); anti-PD-L1 antibody blockade epistasis; PD-L1 expression assay","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with antibody-blocking epistasis establishes PD-L1 as downstream effector; single lab","pmids":["36248854"],"is_preprint":false},{"year":2022,"finding":"The N178T variant (rs3745601, second extracellular loop) of human P2Y4 is a loss-of-function mutation. P2Y4-null mice showed improved glucose tolerance and insulin sensitivity; this improvement was absent in P2Y4/adiponectin double-KO mice, placing adiponectin downstream of P2Y4 in glucose homeostasis regulation.","method":"Functional Ca2+ assay of N178T variant in transfected cells; P2Y4-null mice glucose tolerance test and insulin sensitivity test; P2Y4/adiponectin double-KO mice","journal":"Frontiers in pharmacology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — functional variant characterization combined with double-KO epistasis; single lab; genetic epistasis supports mechanism","pmids":["36532779"],"is_preprint":false},{"year":2025,"finding":"P2Y4-null ischemic mice show increased plasma PD-L1+ exosomes and adiponectin-associated exosomes from adipocyte origin. Inhibition of exosome release (GW4869) abolished the reduction in cardiac fibrosis and T cell infiltration observed in P2Y4-null mice and prevented plasma PD-L1 increase. P2Y4-null pericardial adipose tissue showed increased CDH13/T-cadherin expression (required for adiponectin-driven exosome biogenesis). Exosomes from P2Y4-null ischemic mice polarized macrophages to anti-inflammatory M2c phenotype in vitro.","method":"P2Y4-null mice; GW4869 exosome inhibitor treatment epistasis; nanoparticle tracking analysis; TEM; Western blot (CD63, adiponectin); flow cytometry (PD-L1+ exosomes); in vitro macrophage polarization assay","journal":"Frontiers in pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological epistasis with exosome inhibitor plus multiple orthogonal characterization methods; single lab","pmids":["41164751"],"is_preprint":false}],"current_model":"P2Y4 is a Gq-coupled (and conditionally Gi/o-coupled) GPCR activated primarily by UTP (and in rodents also ATP), which signals through PLC/IP3/Ca2+, RhoA/Rho kinase, PI3K/Akt, and MAPK pathways; its activity is terminated by agonist-driven phosphorylation of Ser-333/Ser-334 leading to desensitization and internalization, it is sorted to the apical membrane of polarized epithelia via a hydrophobic C-terminal targeting signal, forms homo- and hetero-oligomers, couples to M-type K+ and N-type Ca2+ channels in neurons, and in vivo regulates epithelial ion transport (Cl−, K+, Na+), cardiac angiogenesis and postnatal development, glucose homeostasis via adiponectin, and post-ischemic cardiac inflammation via the ET-1/PD-L1/exosome axis."},"narrative":{"mechanistic_narrative":"P2RY4 (P2Y4) is a pyrimidinergic G-protein-coupled receptor that couples to phospholipase C to generate inositol trisphosphate and mobilize intracellular Ca2+ in response to extracellular nucleotides [PMID:8997625]. UTP is the primary full agonist of the human receptor, where ATP behaves as a competitive antagonist, whereas the rodent orthologs are activated equipotently by UTP and ATP — a species difference traced to residues in the second extracellular loop and N-terminus (including Asn-177/Y197) that govern ATP agonism versus antagonism [PMID:10779375, PMID:14670966, PMID:31812541]. The receptor is pharmacologically distinguished from other P2Y subtypes by its insensitivity to suramin and PPADS [PMID:8968535, PMID:9647463, PMID:9751165]. Beyond Gq/PLC, P2Y4 engages Gi/o (pertussis-toxin-sensitive) coupling, RhoA/Rho-kinase-driven actin remodeling, PI3K/Akt, and ERK/p38/JNK MAPK cascades that drive proliferation and immediate-early/AP-1 transcription [PMID:8997625, PMID:10843869, PMID:15649700, PMID:24001770]. Signaling is terminated by agonist-promoted phosphorylation of carboxy-terminal Ser-333/Ser-334, which mediates desensitization and internalization [PMID:11114308], and the receptor is delivered to the apical membrane of polarized epithelia by an autonomous hydrophobic 23-residue C-terminal sorting signal [PMID:23054062]. P2Y4 assembles into homo-oligomers and selective hetero-oligomers with P2Y6, and co-localizes with NMDAR1 [PMID:18404459, PMID:17481575, PMID:15383322]. Functionally, it couples to M-type K+ and N-type Ca2+ channels and to Ca2+-activated K+ channels in neurons and heterologous systems [PMID:12540532, PMID:16075244], and is required in vivo for nucleotide-regulated epithelial Cl-, K+, and Na+ transport [PMID:12644577, PMID:15718265, PMID:16056234, PMID:20220010]. P2Y4-null mice further reveal roles in postnatal cardiac growth via endothelial PDGF-B signaling [PMID:22437266], in post-ischemic cardiac inflammation through an ET-1/PD-L1/exosome and adiponectin axis [PMID:25595790, PMID:36248854, PMID:41164751], and in glucose homeostasis, where the human loss-of-function N178T variant and adiponectin-dependent epistasis link the receptor to insulin sensitivity [PMID:36532779, PMID:27855539].","teleology":[{"year":1996,"claim":"Established the molecular identity and signaling output of P2Y4 — that the cloned receptor is a UTP-preferring pyrimidinergic GPCR coupling to PLC, resolving its place among purinoceptors.","evidence":"Genomic cloning, tissue Northern/RT-PCR, and stable expression in 1321N1 cells with IP accumulation and pertussis toxin block","pmids":["8997625","8617367","8968535"],"confidence":"High","gaps":["Dual Gq/Gi coupling inferred from PTX block only, no direct G-protein reconstitution","Endogenous tissue function not addressed"]},{"year":1998,"claim":"Defined a species-specific pharmacology — rodent P2Y4 is activated equipotently by ATP and UTP while human P2Y4 is not — a distinction critical for interpreting all cross-species functional studies.","evidence":"Rat genomic cloning and pharmacological characterization in transfected and native aortic smooth muscle cells, with MAPK and proliferation readouts","pmids":["9647463","9751165","9690862"],"confidence":"High","gaps":["Structural basis of species difference not yet localized","Physiological relevance of smooth-muscle proliferation untested in vivo"]},{"year":2000,"claim":"Quantified the ATP antagonism at human P2Y4 and identified Ser-333/Ser-334 phosphorylation as the desensitization/internalization switch, defining how receptor activity is terminated.","evidence":"Schild analysis of Ca2+ responses in 1321N1 cells; truncation/point mutagenesis with 32P radiolabeling and surface receptor quantitation; RhoA dominant-negative and C3 exoenzyme assays","pmids":["10779375","11114308","10843869"],"confidence":"High","gaps":["Kinase responsible for Ser-333/334 phosphorylation not identified","Arrestin/clathrin machinery of internalization not defined"]},{"year":2003,"claim":"Localized the determinants of ATP agonism to EL2/N-terminus and showed P2Y4 controls neuronal ion channels, linking receptor structure to effector coupling.","evidence":"Human/rat chimeric and point mutagenesis with Ca2+ assays; electrophysiological reconstitution in rat sympathetic neurons with PTX and transducin Gα","pmids":["14670966","12540532"],"confidence":"High","gaps":["Full orthosteric pocket structure not resolved","Endogenous neuronal agonist source unaddressed"]},{"year":2003,"claim":"Demonstrated that P2Y4 self-assembles into disulfide-linked homo-oligomers, raising the question of oligomerization-dependent function.","evidence":"Differential co-immunoprecipitation of tagged constructs; reducing/non-reducing SDS-PAGE","pmids":["18404459"],"confidence":"Medium","gaps":["Functional consequence of oligomerization not established","Single lab"]},{"year":2005,"claim":"Genetic knockout established P2Y4 as the essential receptor for nucleotide-regulated epithelial Cl- and K+ transport in intestine, moving from heterologous pharmacology to physiological necessity.","evidence":"P2Y4-null, P2Y2-null, and double-KO mice with Ussing-chamber short-circuit current; Xenopus oocyte co-expression with BK/IK channels","pmids":["12644577","15718265","16056234","16075244"],"confidence":"High","gaps":["Coupling between receptor and specific channels in native epithelium correlative","Apical channel identity in vivo not fully resolved"]},{"year":2005,"claim":"Showed P2Y4 drives neuronal differentiation and immediate-early/AP-1 transcription, extending its role beyond ion transport into developmental gene programs.","evidence":"Transfection of SH-SY5Y cells with UTP stimulation; morphology, NFL immunostaining, RT-PCR for cdk-5/NeuroD6, AP-1 reporters","pmids":["15649700"],"confidence":"Medium","gaps":["Performed in overexpression system","Endogenous neuronal contribution not isolated"]},{"year":2007,"claim":"Refined oligomerization biology by showing endogenous P2Y4 forms selective P2Y6 hetero-oligomers and partitions into lipid rafts in native neurons.","evidence":"Blue Native PAGE, co-IP, and lipid raft fractionation from synaptosomes and PC12 cells","pmids":["17481575"],"confidence":"Medium","gaps":["Signaling output of P2Y4/P2Y6 heteromers not determined","Single lab"]},{"year":2012,"claim":"Defined the apical-sorting signal and established a developmental cardiac function, connecting receptor trafficking and endothelial signaling to postnatal heart growth.","evidence":"Mutagenesis/chimera localization in polarized MDCK/Caco-2 cells; P2Y4-null mice with endothelial proliferation, migration, and PDGF-B assays","pmids":["23054062","22437266"],"confidence":"Medium","gaps":["Trafficking machinery recognizing the hydrophobic signal unidentified","Endothelial-cardiomyocyte crosstalk mechanism correlative"]},{"year":2013,"claim":"Showed P2Y4 drives microglial pinocytosis via PI3K/Akt, implicating it in nucleotide-driven uptake including amyloid-beta.","evidence":"siRNA knockdown and PI3K/Akt inhibitors with fluorescence pinocytosis assay","pmids":["24001770"],"confidence":"Medium","gaps":["Direct receptor-to-PI3K coupling not biochemically mapped","In vivo relevance untested"]},{"year":2016,"claim":"Placed adiponectin downstream of P2Y4 in cardiac adipogenesis and identified a role in glutamatergic neuron specification, broadening the receptor's developmental and metabolic reach.","evidence":"P2Y4-null and P2Y4/adiponectin double-KO epistasis with adipogenic and adiponectin assays; ESC/NSC differentiation with P2Y4 pharmacology and vGluT/TBR1 staining","pmids":["27855539","26972684"],"confidence":"Medium","gaps":["Mechanism linking receptor to adiponectin transcription unresolved","Neuronal specification shown pharmacologically, no genetic NSC deletion"]},{"year":2019,"claim":"Implicated P2Y4 in neuroinflammation, showing HIV-1 Tat upregulates the receptor and P2Y4 signaling drives cytokine production via PI3K/Akt and ERK.","evidence":"siRNA knockdown in vitro and in vivo, pathway inhibitors, cytokine and apoptosis readouts","pmids":["30947729"],"confidence":"Medium","gaps":["Direct receptor-Tat relationship not biochemically defined","Single lab"]},{"year":2022,"claim":"Mapped the cardioprotective consequences of P2Y4 loss to PD-L1- and adiponectin-dependent anti-inflammatory pathways, and characterized a human loss-of-function variant linking the receptor to glucose homeostasis.","evidence":"P2Y4-null mice with LAD ligation, flow cytometry, anti-PD-L1 blockade epistasis; N178T variant Ca2+ assay and P2Y4/adiponectin double-KO glucose tolerance tests","pmids":["36248854","36532779"],"confidence":"Medium","gaps":["PD-L1 and adiponectin placed downstream by epistasis but direct transcriptional control not shown","Human variant phenotype based on rodent mechanism"]},{"year":2025,"claim":"Integrated the cardioprotection axis into an exosome-mediated mechanism, showing PD-L1+ and adiponectin-associated exosomes from P2Y4-null adipose tissue polarize macrophages and reduce fibrosis.","evidence":"P2Y4-null mice with GW4869 exosome-inhibitor epistasis, nanoparticle tracking, TEM, CDH13 Western blot, in vitro macrophage polarization","pmids":["41164751"],"confidence":"Medium","gaps":["Causal chain from receptor to exosome biogenesis correlative","Single lab"]},{"year":null,"claim":"How agonist binding is structurally transduced to selective G-protein, channel, and oligomer-dependent outputs, and whether the ET-1/PD-L1/adiponectin/exosome cardiac axis operates in humans, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No experimental receptor structure","Human in vivo cardiac/metabolic mechanism rests on rodent KO inference","Kinase and trafficking machinery for desensitization and apical sorting unidentified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,5,13]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[13,20,24]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[7,10,26]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,6,13]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[11,17,19,24]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[28,33,35]}],"complexes":[],"partners":["P2RY6","GRIN1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P51582","full_name":"P2Y purinoceptor 4","aliases":["P2P","Uridine nucleotide receptor","UNR"],"length_aa":365,"mass_kda":41.0,"function":"Receptor for UTP and UDP coupled to G-proteins that activate a phosphatidylinositol-calcium second messenger system. Not activated by ATP or ADP","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P51582/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/P2RY4","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/P2RY4","total_profiled":1310},"omim":[{"mim_id":"607793","title":"PETER PAN, DROSOPHILA, HOMOLOG OF; PPAN","url":"https://www.omim.org/entry/607793"},{"mim_id":"300038","title":"PYRIMIDINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 4; P2RY4","url":"https://www.omim.org/entry/300038"},{"mim_id":"188060","title":"THROMBOSPONDIN I; THBS1","url":"https://www.omim.org/entry/188060"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in single","driving_tissues":[{"tissue":"intestine","ntpm":2.1}],"url":"https://www.proteinatlas.org/search/P2RY4"},"hgnc":{"alias_symbol":["NRU","P2Y4","UNR","P2P"],"prev_symbol":[]},"alphafold":{"accession":"P51582","domains":[{"cath_id":"1.20.1070.10","chopping":"34-228_240-311","consensus_level":"high","plddt":94.2192,"start":34,"end":311}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P51582","model_url":"https://alphafold.ebi.ac.uk/files/AF-P51582-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P51582-F1-predicted_aligned_error_v6.png","plddt_mean":82.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=P2RY4","jax_strain_url":"https://www.jax.org/strain/search?query=P2RY4"},"sequence":{"accession":"P51582","fasta_url":"https://rest.uniprot.org/uniprotkb/P51582.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P51582/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P51582"}},"corpus_meta":[{"pmid":"16000618","id":"PMC_16000618","title":"Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus.","date":"2005","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16000618","citation_count":187,"is_preprint":false},{"pmid":"9647463","id":"PMC_9647463","title":"Molecular cloning and characterization of rat P2Y4 nucleotide receptor.","date":"1998","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9647463","citation_count":161,"is_preprint":false},{"pmid":"8997625","id":"PMC_8997625","title":"Pharmacological characterization of the human P2Y4 receptor.","date":"1996","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8997625","citation_count":130,"is_preprint":false},{"pmid":"14581177","id":"PMC_14581177","title":"Extended pharmacological profiles of rat P2Y2 and rat P2Y4 receptors and their sensitivity to extracellular H+ and Zn2+ ions.","date":"2003","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/14581177","citation_count":125,"is_preprint":false},{"pmid":"14564529","id":"PMC_14564529","title":"Localisation of P2Y1 and P2Y4 receptors in dorsal root, nodose and trigeminal ganglia of the rat.","date":"2003","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/14564529","citation_count":115,"is_preprint":false},{"pmid":"9751165","id":"PMC_9751165","title":"Molecular cloning and characterization of the rat P2Y4 receptor.","date":"1998","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9751165","citation_count":98,"is_preprint":false},{"pmid":"10779375","id":"PMC_10779375","title":"ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor.","date":"2000","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10779375","citation_count":90,"is_preprint":false},{"pmid":"10843869","id":"PMC_10843869","title":"P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes.","date":"2000","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10843869","citation_count":88,"is_preprint":false},{"pmid":"17125260","id":"PMC_17125260","title":"Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors.","date":"2006","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17125260","citation_count":85,"is_preprint":false},{"pmid":"8968535","id":"PMC_8968535","title":"Cloned and transfected P2Y4 receptors: characterization of a suramin and PPADS-insensitive response to UTP.","date":"1996","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8968535","citation_count":81,"is_preprint":false},{"pmid":"9690862","id":"PMC_9690862","title":"Evidence that P2Y4 nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP.","date":"1998","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9690862","citation_count":81,"is_preprint":false},{"pmid":"11754592","id":"PMC_11754592","title":"Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.","date":"2002","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11754592","citation_count":76,"is_preprint":false},{"pmid":"12644577","id":"PMC_12644577","title":"Loss of nucleotide regulation of epithelial chloride transport in the jejunum of P2Y4-null mice.","date":"2003","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12644577","citation_count":72,"is_preprint":false},{"pmid":"15718265","id":"PMC_15718265","title":"K+ secretion activated by luminal P2Y2 and P2Y4 receptors in mouse colon.","date":"2005","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15718265","citation_count":65,"is_preprint":false},{"pmid":"15452043","id":"PMC_15452043","title":"Expression of P2Y1, P2Y2, P2Y4, and P2Y6 receptor subtypes in the rat retina.","date":"2004","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/15452043","citation_count":60,"is_preprint":false},{"pmid":"24001770","id":"PMC_24001770","title":"P2Y4 receptor-mediated pinocytosis contributes to amyloid beta-induced self-uptake by microglia.","date":"2013","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24001770","citation_count":60,"is_preprint":false},{"pmid":"11290369","id":"PMC_11290369","title":"Molecular cloning and characterization of the mouse P2Y4 nucleotide receptor.","date":"2001","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11290369","citation_count":58,"is_preprint":false},{"pmid":"12603858","id":"PMC_12603858","title":"Human keratinocytes express multiple P2Y-receptors: evidence for functional P2Y1, P2Y2, and P2Y4 receptors.","date":"2003","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/12603858","citation_count":58,"is_preprint":false},{"pmid":"16056234","id":"PMC_16056234","title":"The role of epithelial P2Y2 and P2Y4 receptors in the regulation of intestinal chloride secretion.","date":"2005","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16056234","citation_count":57,"is_preprint":false},{"pmid":"26042493","id":"PMC_26042493","title":"A Study on UV Filter Chemicals from Annex VII of European Union Directive 76/768/EEC, in the In Vitro 3T3 NRU Phototoxicity Test.","date":"1998","source":"Alternatives to laboratory animals : ATLA","url":"https://pubmed.ncbi.nlm.nih.gov/26042493","citation_count":56,"is_preprint":false},{"pmid":"11891569","id":"PMC_11891569","title":"Immunolocalization of P2Y4 and P2Y2 purinergic receptors in strial marginal cells and vestibular dark cells.","date":"2002","source":"The Journal of membrane biology","url":"https://pubmed.ncbi.nlm.nih.gov/11891569","citation_count":51,"is_preprint":false},{"pmid":"11114308","id":"PMC_11114308","title":"Differential regulation of the uridine nucleotide-activated P2Y4 and P2Y6 receptors. SER-333 and SER-334 in the carboxyl terminus are involved in agonist-dependent phosphorylation desensitization and internalization of the P2Y4 receptor.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11114308","citation_count":49,"is_preprint":false},{"pmid":"12623123","id":"PMC_12623123","title":"Tumor necrosis factor alpha-induced apoptosis in astrocytes is prevented by the activation of P2Y6, but not P2Y4 nucleotide receptors.","date":"2003","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12623123","citation_count":49,"is_preprint":false},{"pmid":"12694404","id":"PMC_12694404","title":"Characterization of P2X3, P2Y1 and P2Y4 receptors in cultured HEK293-hP2X3 cells and their inhibition by ethanol and trichloroethanol.","date":"2003","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12694404","citation_count":48,"is_preprint":false},{"pmid":"14689471","id":"PMC_14689471","title":"Mechanically evoked reflex electrogenic chloride secretion in rat distal colon is triggered by endogenous nucleotides acting at P2Y1, P2Y2, and P2Y4 receptors.","date":"2004","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/14689471","citation_count":48,"is_preprint":false},{"pmid":"16359641","id":"PMC_16359641","title":"Structure activity and molecular modeling analyses of ribose- and base-modified uridine 5'-triphosphate analogues at the human P2Y2 and P2Y4 receptors.","date":"2005","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16359641","citation_count":47,"is_preprint":false},{"pmid":"30947729","id":"PMC_30947729","title":"HIV-1 Tat enhances purinergic P2Y4 receptor signaling to mediate inflammatory cytokine production and neuronal damage via PI3K/Akt and ERK MAPK pathways.","date":"2019","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/30947729","citation_count":42,"is_preprint":false},{"pmid":"17481575","id":"PMC_17481575","title":"Comparative analysis of P2Y4 and P2Y6 receptor architecture in native and transfected neuronal systems.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17481575","citation_count":41,"is_preprint":false},{"pmid":"17391276","id":"PMC_17391276","title":"P2Y2- and P2Y4 purinergic receptors are over-expressed in human colon cancer.","date":"2007","source":"Autonomic & autacoid pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17391276","citation_count":41,"is_preprint":false},{"pmid":"21417463","id":"PMC_21417463","title":"Structural modifications of UMP, UDP, and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6 receptors.","date":"2011","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21417463","citation_count":41,"is_preprint":false},{"pmid":"16616701","id":"PMC_16616701","title":"Region-specific distribution of the P2Y4 receptor in enteric glial cells and interstitial cells of Cajal within the guinea-pig gastrointestinal tract.","date":"2006","source":"Autonomic neuroscience : basic & clinical","url":"https://pubmed.ncbi.nlm.nih.gov/16616701","citation_count":39,"is_preprint":false},{"pmid":"14670966","id":"PMC_14670966","title":"Agonist versus antagonist action of ATP at the P2Y4 receptor is determined by the second extracellular loop.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14670966","citation_count":39,"is_preprint":false},{"pmid":"12540532","id":"PMC_12540532","title":"Coupling of the nucleotide P2Y4 receptor to neuronal ion channels.","date":"2003","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12540532","citation_count":39,"is_preprint":false},{"pmid":"9037032","id":"PMC_9037032","title":"The proliferation potential protein-related (P2P-R) gene with domains encoding heterogeneous nuclear ribonucleoprotein association and Rb1 binding shows repressed expression during terminal differentiation.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9037032","citation_count":37,"is_preprint":false},{"pmid":"21528910","id":"PMC_21528910","title":"Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate δ-ester modifications as selective agonists of the P2Y(4) receptor.","date":"2011","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21528910","citation_count":37,"is_preprint":false},{"pmid":"15649700","id":"PMC_15649700","title":"The metabotropic P2Y4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells.","date":"2005","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/15649700","citation_count":36,"is_preprint":false},{"pmid":"25595790","id":"PMC_25595790","title":"Loss of mouse P2Y4 nucleotide receptor protects against myocardial infarction through endothelin-1 downregulation.","date":"2015","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25595790","citation_count":31,"is_preprint":false},{"pmid":"28306255","id":"PMC_28306255","title":"Development of Potent and Selective Antagonists for the UTP-Activated P2Y4 Receptor.","date":"2017","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28306255","citation_count":30,"is_preprint":false},{"pmid":"18625291","id":"PMC_18625291","title":"Localization and possible function of P2Y(4) receptors in the rodent retina.","date":"2008","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18625291","citation_count":30,"is_preprint":false},{"pmid":"16075244","id":"PMC_16075244","title":"P2Y2 and P2Y4 receptors regulate pancreatic Ca(2+)-activated K+ channels differently.","date":"2005","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16075244","citation_count":28,"is_preprint":false},{"pmid":"15383322","id":"PMC_15383322","title":"Role of the metabotropic P2Y(4) receptor during hypoglycemia: cross talk with the ionotropic NMDAR1 receptor.","date":"2004","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/15383322","citation_count":28,"is_preprint":false},{"pmid":"22437266","id":"PMC_22437266","title":"P2Y(4) nucleotide receptor: a novel actor in post-natal cardiac development.","date":"2012","source":"Angiogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/22437266","citation_count":25,"is_preprint":false},{"pmid":"12384997","id":"PMC_12384997","title":"P2P-R protein overexpression restricts mitotic progression at prometaphase and promotes mitotic apoptosis.","date":"2002","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12384997","citation_count":24,"is_preprint":false},{"pmid":"12064457","id":"PMC_12064457","title":"P2P-R protein localizes to the nucleolus of interphase cells and the periphery of chromosomes in mitotic cells which show maximum P2P-R immunoreactivity.","date":"2002","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12064457","citation_count":24,"is_preprint":false},{"pmid":"19900397","id":"PMC_19900397","title":"ATP modulates transcription factors through P2Y2 and P2Y4 receptors via PKC/MAPKs and PKC/Src pathways in MCF-7 cells.","date":"2009","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/19900397","citation_count":22,"is_preprint":false},{"pmid":"27855539","id":"PMC_27855539","title":"Mouse P2Y4 Nucleotide Receptor Is a Negative Regulator of Cardiac Adipose-Derived Stem Cell Differentiation and Cardiac Fat Formation.","date":"2016","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/27855539","citation_count":22,"is_preprint":false},{"pmid":"11401851","id":"PMC_11401851","title":"Apical P2Y4 purinergic receptor controls K+ secretion by vestibular dark cell epithelium.","date":"2001","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11401851","citation_count":20,"is_preprint":false},{"pmid":"22118339","id":"PMC_22118339","title":"In vitro induction of apoptosis, necrosis and genotoxicity by cosmetic preservatives: application of flow cytometry as a complementary analysis by NRU.","date":"2011","source":"International journal of cosmetic science","url":"https://pubmed.ncbi.nlm.nih.gov/22118339","citation_count":20,"is_preprint":false},{"pmid":"12938151","id":"PMC_12938151","title":"Functional potential of P2P-R: a role in the cell cycle and cell differentiation related to its interactions with proteins that bind to matrix associated regions of DNA?","date":"2003","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12938151","citation_count":19,"is_preprint":false},{"pmid":"31005663","id":"PMC_31005663","title":"P2Y4/TSP-1/TGF-β1/pSmad2/3 pathway contributes to acute generalized seizures induced by kainic acid.","date":"2019","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/31005663","citation_count":19,"is_preprint":false},{"pmid":"8439573","id":"PMC_8439573","title":"Exon skipping in the expression of the gene immediately upstream of N-ras (unr/NRU).","date":"1993","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/8439573","citation_count":19,"is_preprint":false},{"pmid":"22865387","id":"PMC_22865387","title":"Gene deletion of P2Y4 receptor lowers exercise capacity and reduces myocardial hypertrophy with swimming exercise.","date":"2012","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22865387","citation_count":19,"is_preprint":false},{"pmid":"14566974","id":"PMC_14566974","title":"Stable overexpression of specific segments of the P2P-R protein in human MCF-7 cells promotes camptothecin-induced apoptosis.","date":"2003","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/14566974","citation_count":19,"is_preprint":false},{"pmid":"8617367","id":"PMC_8617367","title":"Molecular cloning and characterization of a novel orphan receptor (P2P) expressed in human pancreas that shows high structural homology to the P2U purinoceptor.","date":"1996","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8617367","citation_count":19,"is_preprint":false},{"pmid":"18404459","id":"PMC_18404459","title":"The P2Y₄ receptor forms homo-oligomeric complexes in several CNS and PNS neuronal cells.","date":"2006","source":"Purinergic signalling","url":"https://pubmed.ncbi.nlm.nih.gov/18404459","citation_count":18,"is_preprint":false},{"pmid":"16266433","id":"PMC_16266433","title":"Apical membrane P2Y4 purinergic receptor controls K+ secretion by strial marginal cell epithelium.","date":"2005","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/16266433","citation_count":18,"is_preprint":false},{"pmid":"24712832","id":"PMC_24712832","title":"4-Alkyloxyimino derivatives of uridine-5'-triphosphate: distal modification of potent agonists as a strategy for molecular probes of P2Y2, P2Y4, and P2Y6 receptors.","date":"2014","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24712832","citation_count":16,"is_preprint":false},{"pmid":"21769584","id":"PMC_21769584","title":"Regional expression of P2Y(4) receptors in the rat central nervous system.","date":"2011","source":"Purinergic signalling","url":"https://pubmed.ncbi.nlm.nih.gov/21769584","citation_count":16,"is_preprint":false},{"pmid":"14552422","id":"PMC_14552422","title":"Localization of the P2Y4 receptor in the guinea pig organ of Corti.","date":"2003","source":"Journal of the American Academy of Audiology","url":"https://pubmed.ncbi.nlm.nih.gov/14552422","citation_count":14,"is_preprint":false},{"pmid":"17882567","id":"PMC_17882567","title":"KCNQ1/KCNE1 K+ channel and P2Y4 receptor are co-expressed from the time of birth in the apical membrane of rat strial marginal cells.","date":"2007","source":"Acta oto-laryngologica. Supplementum","url":"https://pubmed.ncbi.nlm.nih.gov/17882567","citation_count":13,"is_preprint":false},{"pmid":"15617101","id":"PMC_15617101","title":"P2P-R expression is genetically coregulated with components of the translation machinery and with PUM2, a translational repressor that associates with the P2P-R mRNA.","date":"2005","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15617101","citation_count":12,"is_preprint":false},{"pmid":"17433586","id":"PMC_17433586","title":"Changes in P2Y4 receptor expression in rat cochlear outer sulcus cells during development.","date":"2007","source":"Hearing research","url":"https://pubmed.ncbi.nlm.nih.gov/17433586","citation_count":12,"is_preprint":false},{"pmid":"16176447","id":"PMC_16176447","title":"Demonstration of P2Y4 purinergic receptors in the HT-29 human colon cancer cell line.","date":"2005","source":"Autonomic & autacoid pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16176447","citation_count":12,"is_preprint":false},{"pmid":"27384918","id":"PMC_27384918","title":"Functional and molecular evidence for heteromeric association of P2Y1 receptor with P2Y2 and P2Y4 receptors in mouse granulocytes.","date":"2016","source":"BMC pharmacology & toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/27384918","citation_count":11,"is_preprint":false},{"pmid":"20220010","id":"PMC_20220010","title":"P2Y4-mediated regulation of Na+ absorption in the Reissner's membrane of the cochlea.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20220010","citation_count":11,"is_preprint":false},{"pmid":"31812541","id":"PMC_31812541","title":"Ligand binding and activation of UTP-activated G protein-coupled P2Y2 and P2Y4 receptors elucidated by mutagenesis, pharmacological and computational studies.","date":"2019","source":"Biochimica et biophysica acta. General subjects","url":"https://pubmed.ncbi.nlm.nih.gov/31812541","citation_count":11,"is_preprint":false},{"pmid":"26972684","id":"PMC_26972684","title":"P2Y4 Nucleotide Receptor in Neuronal Precursors Induces Glutamatergic Subtype Markers in Their Descendant Neurons.","date":"2016","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26972684","citation_count":9,"is_preprint":false},{"pmid":"12553003","id":"PMC_12553003","title":"P2P-R deficiency modifies nocodazole-induced mitotic arrest and UV-induced apoptosis.","date":"2002","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/12553003","citation_count":9,"is_preprint":false},{"pmid":"14599479","id":"PMC_14599479","title":"The benefits of the 3T3 NRU test in the safety assessment of cosmetics: long-term experience from pre-marketing testing in the Czech Republic.","date":"2003","source":"Toxicology in vitro : an international journal published in association with BIBRA","url":"https://pubmed.ncbi.nlm.nih.gov/14599479","citation_count":9,"is_preprint":false},{"pmid":"34601296","id":"PMC_34601296","title":"Synthesis, characterization and biological evaluation of indomethacin derived thioureas as purinergic (P2Y1, P2Y2, P2Y4, and P2Y6) receptor antagonists.","date":"2021","source":"Bioorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34601296","citation_count":9,"is_preprint":false},{"pmid":"19606587","id":"PMC_19606587","title":"Comparative analysis of 1-phenyl-2-propanone (P2P), an amphetamine-type stimulant precursor, using stable isotope ratio mass spectrometry: presented in part as a poster at the 2nd meeting of the Joint European Stable Isotope User Meeting (JESIUM), Giens, France, September 2008.","date":"2009","source":"Science & justice : journal of the Forensic Science Society","url":"https://pubmed.ncbi.nlm.nih.gov/19606587","citation_count":9,"is_preprint":false},{"pmid":"33232731","id":"PMC_33232731","title":"P2Y4, P2Y6 and P2Y11 receptors: From the early days of cloning to their function.","date":"2020","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33232731","citation_count":7,"is_preprint":false},{"pmid":"20184719","id":"PMC_20184719","title":"Systems genetics analyses predict a transcription role for P2P-R: molecular confirmation that P2P-R is a transcriptional co-repressor.","date":"2010","source":"BMC systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/20184719","citation_count":7,"is_preprint":false},{"pmid":"18436624","id":"PMC_18436624","title":"ATP induces guinea pig gallbladder smooth muscle excitability via the P2Y4 receptor and COX-1 activity.","date":"2008","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18436624","citation_count":6,"is_preprint":false},{"pmid":"15665982","id":"PMC_15665982","title":"Activation of a P2Y4-like purinoceptor triggers an increase in cytosolic [Ca2+] in the red blood cells of the lizard Ameiva ameiva (Squamata, Teiidae).","date":"2005","source":"Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas","url":"https://pubmed.ncbi.nlm.nih.gov/15665982","citation_count":6,"is_preprint":false},{"pmid":"30069871","id":"PMC_30069871","title":"Nucleotide receptor P2RY4 is required for head formation via induction and maintenance of head organizer in Xenopus laevis.","date":"2018","source":"Development, growth & differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/30069871","citation_count":4,"is_preprint":false},{"pmid":"36248854","id":"PMC_36248854","title":"Central role of PD-L1 in cardioprotection resulting from P2Y4 nucleotide receptor loss.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36248854","citation_count":4,"is_preprint":false},{"pmid":"38731872","id":"PMC_38731872","title":"Testosterone Enhances KV Currents and Airway Smooth Muscle Relaxation Induced by ATP and UTP through P2Y4 Receptors and Adenylyl Cyclase Pathway.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38731872","citation_count":4,"is_preprint":false},{"pmid":"23054062","id":"PMC_23054062","title":"Apical targeting of the P2Y(4) receptor is directed by hydrophobic and basic residues in the cytoplasmic tail.","date":"2012","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23054062","citation_count":4,"is_preprint":false},{"pmid":"17496318","id":"PMC_17496318","title":"Rapid assessment of correlated amino acids from pair-to-pair (P2P) substitution matrices.","date":"2007","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17496318","citation_count":4,"is_preprint":false},{"pmid":"26550244","id":"PMC_26550244","title":"Expression of purinergic receptor P2Y4 in Schwann cell following nerve regeneration.","date":"2015","source":"International journal of clinical and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26550244","citation_count":3,"is_preprint":false},{"pmid":"36105291","id":"PMC_36105291","title":"Knockdown of P2Y4 ameliorates sepsis-induced acute kidney injury in mice via inhibiting the activation of the NF-κB/MMP8 axis.","date":"2022","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/36105291","citation_count":3,"is_preprint":false},{"pmid":"16839719","id":"PMC_16839719","title":"Reactive blue 2, an antagonist of rat P2Y4, increases K+ secretion in rat cochlea strial marginal cells.","date":"2006","source":"Hearing research","url":"https://pubmed.ncbi.nlm.nih.gov/16839719","citation_count":3,"is_preprint":false},{"pmid":"23581161","id":"PMC_23581161","title":"An in vitro phototoxicity assay battery (photohaemolysis and 3T3 NRU PT test) to assess phototoxic potential of fragrances.","date":"2004","source":"Alternatives to laboratory animals : ATLA","url":"https://pubmed.ncbi.nlm.nih.gov/23581161","citation_count":3,"is_preprint":false},{"pmid":"23567840","id":"PMC_23567840","title":"Protein kinase C-mediated ATP stimulation of Na(+)-ATPase activity in LLC-PK1 cells involves a P2Y2 and/or P2Y4 receptor.","date":"2013","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/23567840","citation_count":3,"is_preprint":false},{"pmid":"15020308","id":"PMC_15020308","title":"Aalpha,beta-methylene ATP enhances P2Y4 contraction of rabbit basilar artery.","date":"2004","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15020308","citation_count":3,"is_preprint":false},{"pmid":"36532779","id":"PMC_36532779","title":"Loss-of-function N178T variant of the human P2Y4 receptor is associated with decreased severity of coronary artery disease and improved glucose homeostasis.","date":"2022","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36532779","citation_count":2,"is_preprint":false},{"pmid":"12513796","id":"PMC_12513796","title":"[Sal I, Nru I and Mse I restriction fragment length polymorphisms of factor IX gene in Chinese Han people].","date":"2002","source":"Zhongguo shi yan xue ye xue za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/12513796","citation_count":0,"is_preprint":false},{"pmid":"22293032","id":"PMC_22293032","title":"P2P proteomics -- data sharing for enhanced protein identification.","date":"2012","source":"Automated experimentation","url":"https://pubmed.ncbi.nlm.nih.gov/22293032","citation_count":0,"is_preprint":false},{"pmid":"41164751","id":"PMC_41164751","title":"Identification of an anti-inflammatory action of exosome release in P2Y4 loss-mediated cardioprotection.","date":"2025","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41164751","citation_count":0,"is_preprint":false},{"pmid":"36591760","id":"PMC_36591760","title":"IN VIVO ACTIVATION OF P2Y4 PURINERGIC RECEPTORS USING ATP IN RAT EPIDERMAL TISSUE.","date":"2022","source":"Wiadomosci lekarskie (Warsaw, Poland : 1960)","url":"https://pubmed.ncbi.nlm.nih.gov/36591760","citation_count":0,"is_preprint":false},{"pmid":"36389796","id":"PMC_36389796","title":"Corrigendum: Central role of PD-L1 in cardioprotection resulting from P2Y4 nucleotide receptor loss.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36389796","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.07.31.668016","title":"Developing a Novel  <i>In Vitro</i>  Toxicity Assay for Predicting Inhalation Toxicity in Rats","date":"2025-08-02","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.31.668016","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.08.20.25334072","title":"Application of Evidence into Practice in Trauma: The Purpose to Practice (P2P) Approach to Consensus Generation","date":"2025-08-24","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.20.25334072","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.10.24.684369","title":"In vitro multi-assay cytotoxicity assessment of iron oxide nanoparticles on neural cells – addressing spectrophotometric interference","date":"2025-10-26","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.24.684369","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50653,"output_tokens":9512,"usd":0.147319,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19816,"output_tokens":4665,"usd":0.107853,"stage2_stop_reason":"end_turn"},"total_usd":0.255172,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"Human P2Y4 receptor, stably expressed in 1321N1 astrocytoma cells, functions as a pyrimidinergic GPCR that couples to phospholipase C to produce inositol trisphosphates. UTP is the primary full agonist; ATP acts as a pure antagonist at early times and partial agonist later. Pertussis toxin inhibited the early UTP response (~62%), suggesting the receptor can couple to both Gi/o and Gq proteins in a time-dependent manner.\",\n      \"method\": \"Stable transfection in 1321N1 cells; inositol phosphate accumulation assay; pertussis toxin treatment\",\n      \"journal\": \"European journal of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct functional reconstitution in transfected cells with pharmacological dissection; multiple orthogonal methods (IP accumulation, PTX block); replicated across multiple labs\",\n      \"pmids\": [\"8997625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Human P2Y4 receptor (cloned as P2P) is encoded by an intronless single-copy gene, expressed predominantly in pancreas, and encodes a 365 amino acid GPCR with high structural homology to P2U/P2Y purinoceptors within transmembrane domains.\",\n      \"method\": \"Genomic cloning, Northern blot, RT-PCR tissue distribution\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — original cloning with functional domain characterization; single lab but molecular and expression data orthogonal\",\n      \"pmids\": [\"8617367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Human P2Y4 receptor is not antagonized by suramin or PPADS (unlike P2Y1 and P2Y2), defining a pharmacologically distinct profile among cloned P2Y receptors when stably expressed in 1321N1 cells.\",\n      \"method\": \"Stable transfection in 1321N1 cells; pharmacological antagonism assays\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct functional reconstitution; replicated across multiple independent labs\",\n      \"pmids\": [\"8968535\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Rat P2Y4 receptor (rP2Y4), unlike the human ortholog, is activated equipotently by both ATP and UTP (partial agonists: ADP, ATPγS, 2-MeSATP, UDP), making it pharmacologically similar to the P2U receptor subtype but suramin-insensitive (distinguishing it from P2Y2). The receptor is reversibly antagonized by Reactive Blue 2.\",\n      \"method\": \"Rat genomic library cloning; expression and pharmacological characterization in transfected cells\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct cloning and functional reconstitution; replicated by independent lab (Webb et al. 1998)\",\n      \"pmids\": [\"9647463\", \"9751165\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"P2Y4 receptor mediates phospholipase C responses to extracellular UTP and ATP in spontaneously hypertensive rat aortic smooth muscle cells. ATP behaves as a partial agonist compared to UTP; UDP response is abolished by hexokinase, consistent with conversion to UTP. P2Y4 mRNA was confirmed by RT-PCR in these cells. Stimulation activates p42/p44 MAPK, which in turn drives thymidine incorporation (proliferation).\",\n      \"method\": \"RT-PCR; PLC assay; hexokinase competition; MAPK phosphorylation assay; [3H]-thymidine incorporation; comparison with 1321N1 cells transfected with hP2Y4\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal functional assays in native cells confirmed by transfected cell comparison; single lab\",\n      \"pmids\": [\"9690862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"ATP is a competitive antagonist (pA2 = 6.15) at the human P2Y4 receptor but a potent full agonist at the rat P2Y4 receptor, demonstrating a species-specific difference in agonist/antagonist behavior at this receptor. CTP and Ap4A were partial antagonists at hP2Y4.\",\n      \"method\": \"Stable expression in 1321N1 cells; intracellular Ca2+ measurement under conditions minimizing nucleotide metabolism; Schild plot analysis\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — rigorous pharmacological reconstitution with Schild analysis; confirmed species pharmacology difference; replicated by Herold et al. 2003\",\n      \"pmids\": [\"10779375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"P2Y4 receptor (along with P2Y1, P2Y2, P2Y6) couples to RhoA activation and subsequent Rho kinase-dependent actin stress fiber formation in vascular myocytes. Dominant-negative RhoA and C3 exoenzyme blocked this response. Transfection of P2Y4 into Swiss 3T3 cells confirmed Rho kinase-dependent actin reorganization.\",\n      \"method\": \"Dominant-negative RhoA transfection; C3 exoenzyme treatment; Y-27632 Rho kinase inhibition; membrane-bound RhoA quantitation; Swiss 3T3 cell transfection\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (genetic dominant negative, bacterial toxin, pharmacological inhibitor); single lab\",\n      \"pmids\": [\"10843869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Agonist-promoted phosphorylation of human P2Y4 receptor at Ser-333 and Ser-334 in the carboxyl terminus mediates UTP-dependent desensitization and internalization (50% loss of surface receptors). Truncation and point mutagenesis identified these residues as essential; the P2Y4-332 truncation mutant showed no UTP-promoted [32P] phosphorylation. In contrast, P2Y6 receptor does not undergo rapid agonist-dependent desensitization or internalization.\",\n      \"method\": \"Mutagenesis (truncation and point mutations); [32P]Pi radiolabeling; surface receptor quantitation; inositol phosphate desensitization assay in 1321N1 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis combined with radiolabeling and functional assay; multiple mutants tested; rigorous mechanistic dissection in single study\",\n      \"pmids\": [\"11114308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Mouse P2Y4 receptor is equally activated by UTP and ATP (like rat P2Y4), is antagonized by PPADS and Reactive Blue 2, and is not blocked by suramin — confirming the rodent P2Y4 pharmacological profile. mRNA detected in liver, intestine, stomach, bladder, and lung.\",\n      \"method\": \"Mouse genomic library screening; stable expression in 1321N1 cells; pharmacological characterization\",\n      \"journal\": \"European journal of pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — functional reconstitution in transfected cells; single lab; confirms rodent species pharmacology\",\n      \"pmids\": [\"11290369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"P2Y4 receptor at the apical membrane of vestibular dark cell epithelium mediates inhibition of K+ secretion (electrogenic short-circuit current) by UTP, ATP, and diadenosine tetraphosphate but not UDP. Insensitivity to suramin (100 µM) supports P2Y4 identity. The response showed no desensitization over 15 min of sustained agonist exposure.\",\n      \"method\": \"Voltage-sensitive vibrating probe (electrophysiology); RT-PCR for P2Y2/P2Y4; pharmacological profiling with antagonists\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct electrophysiological measurement in native epithelium combined with molecular identification; single lab\",\n      \"pmids\": [\"11401851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"P2Y4 receptor protein is immunolocalized specifically to the apical membrane of strial marginal cells and vestibular dark cells in the gerbil inner ear, while P2Y2 is located basolaterally. Western blot detected a 55 kDa band in stria vascularis for P2Y4.\",\n      \"method\": \"Western blot; fluorescence confocal immunohistochemistry; peptide blocking controls\",\n      \"journal\": \"The Journal of membrane biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct subcellular localization by confocal microscopy with peptide-blocked controls; single lab\",\n      \"pmids\": [\"11891569\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"P2Y4-null mice generated by gene targeting completely lack UTP- and ATP-induced chloride secretion in the jejunum (measured as short-circuit current in Ussing chambers), demonstrating that P2Y4 is required for nucleotide-regulated epithelial chloride transport in the small intestine.\",\n      \"method\": \"Gene targeting knockout; Ussing chamber short-circuit current measurement; RT-PCR confirmation of mRNA loss\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic knockout with quantitative functional readout; replicated and extended in subsequent knockout studies\",\n      \"pmids\": [\"12644577\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The second extracellular loop (EL2) and NH2-terminus of P2Y4 receptor together form a functional motif determining whether ATP acts as an agonist or antagonist. Chimeric receptor analysis and mutagenesis identified three specific residues in EL2 (Asn-177, Ile-183, Leu-190 in hP2Y4) as key determinants of ATP agonism. Replacement of hP2Y4 EL2 with rP2Y4 EL2 converted ATP from antagonist to near-full agonist.\",\n      \"method\": \"Human/rat P2Y4 chimeric receptor expression in 1321N1 cells; point mutagenesis; intracellular Ca2+ assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic chimeric and point mutagenesis with functional reconstitution; multiple constructs; rigorous mechanistic dissection\",\n      \"pmids\": [\"14670966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Human and rat P2Y4 receptors, expressed in rat sympathetic neurons, couple to M-type K+ channels (IC50 ~21–28 nM for UTP) and to N-type Ca2+ channels (IC50 ~273 nM). Ca2+ channel inhibition requires a diffusible intracellular factor lost in ruptured-patch recording and involves Gβγ subunits of Gi/o proteins (blocked by pertussis toxin and transducin Gα). M-current inhibition is PTX-insensitive. P2Y4 couples more effectively to M-type K+ channels than to Ca2+ channels.\",\n      \"method\": \"Nuclear injection of P2Y4 cDNA into rat sympathetic neurons; whole-cell and perforated-patch electrophysiology; PTX pretreatment; transducin Gα co-expression\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct electrophysiological reconstitution in neurons with genetic and pharmacological dissection of G-protein coupling; multiple orthogonal methods\",\n      \"pmids\": [\"12540532\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"P2Y4 receptor forms homo-dimers and higher-order oligomeric complexes, at least partially assembled through disulfide bonds. Co-transfection with differentially tagged P2Y4 constructs followed by differential co-immunoprecipitation directly demonstrated homodimerization.\",\n      \"method\": \"Co-transfection with differentially tagged receptors; co-immunoprecipitation; SDS-PAGE under reducing/non-reducing conditions\",\n      \"journal\": \"Purinergic signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-immunoprecipitation with tagged constructs; single lab; confirmed in follow-up study\",\n      \"pmids\": [\"18404459\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Co-localization of P2Y4 and NMDAR1 receptors at the membrane was demonstrated by confocal double immunofluorescence and confirmed by co-immunoprecipitation in cerebellar granule neurons and HEK-293 cells. During hypoglycemia, P2Y4 expression is induced while NMDAR1 is inhibited; both P2 and NMDA antagonists restore basal expression levels.\",\n      \"method\": \"Co-immunoprecipitation; confocal double immunofluorescence; Western blot during glucose deprivation\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-immunoprecipitation in both native and heterologous cells plus immunofluorescence co-localization; single lab\",\n      \"pmids\": [\"15383322\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"P2Y4 receptor activation by UTP in neuroblastoma SH-SY5Y cells facilitates neuritogenesis (detected by morphological analysis and neurofilament NFL immunostaining), increases transcription of differentiation-linked genes (cdk-5, NeuroD6) and activates AP-1 family transcription factors (c-fos, fos-B, jun-D). Prolonged P2Y4 activation also induces cell death.\",\n      \"method\": \"Transient transfection; morphological phase contrast and confocal microscopy; RT-PCR for immediate-early genes; cytofluorimetric DNA damage assay; AP-1 reporter assays\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal functional readouts after P2Y4 transfection and UTP stimulation; single lab\",\n      \"pmids\": [\"15649700\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Both P2Y2 and P2Y4 receptors present on the luminal membrane of mouse distal colonic mucosa mediate K+ secretion (measured as transepithelial voltage change and blocked by Ba2+ and iberiotoxin). In P2Y2 KO and P2Y4 KO mice the UTP-stimulated K+ secretion was each significantly reduced; in P2Y2/P2Y4 double KO mice it was completely abolished.\",\n      \"method\": \"P2Y2-null and P2Y4-null and double-knockout mice; Ussing chamber electrophysiology; Ba2+ and iberiotoxin (BK channel) blockers; RT-PCR of isolated crypts\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with double knockout providing complete pathway dissection; direct functional readout in native tissue\",\n      \"pmids\": [\"15718265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"P2Y4 receptor at the apical membrane of gerbil strial marginal cells mediates UTP/ATP-induced decrease in K+ secretion via PLC activation and biphasic intracellular Ca2+ elevation (partially blocked by 2-APB, an IP3R/SOC inhibitor). Suramin (100 µM) was without effect, consistent with P2Y4 identity.\",\n      \"method\": \"Short-circuit current measurement with voltage-sensitive probe; intracellular Ca2+ imaging; 2-APB pharmacology; RT-PCR for P2Y subtypes\",\n      \"journal\": \"Cell communication and signaling : CCS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct electrophysiology combined with Ca2+ imaging and molecular identification; single lab\",\n      \"pmids\": [\"16266433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"P2Y4 receptor (not P2Y2) fully mediates chloride secretory response to UTP in mouse colon (both apical and basolateral sides) and in jejunum (apical side). P2Y4-null mice showed abolished colonic chloride secretion to UTP, whereas P2Y2-null mice were unaffected in the colon. The UTP-potentiated forskolin response was also abolished in P2Y4-null jejunum.\",\n      \"method\": \"P2Y2-null and P2Y4-null knockout mice; Ussing chamber short-circuit current; chloride-free medium control; amiloride/phloridzin controls\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout comparison of two receptor subtypes with multiple conditions; extends and confirms PMID 12644577\",\n      \"pmids\": [\"16056234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"P2Y4 receptor co-expressed with BK channels in Xenopus oocytes leads to a ~30% increase in BK current upon UTP stimulation, while P2Y2 co-expressed with BK channels causes ~20% inhibition. Co-expression of P2Y4 with IK channels produces a large 22-fold UTP-stimulated current activation. This demonstrates differential regulation of Ca2+-activated K+ channels by P2Y4 vs P2Y2 subtypes.\",\n      \"method\": \"Xenopus oocyte co-expression; electrophysiological recording of K+ channel activity; UTP stimulation\",\n      \"journal\": \"Pflugers Archiv : European journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct reconstitution in oocyte expression system; two K+ channel types tested; single lab\",\n      \"pmids\": [\"16075244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In native neuronal cells, P2Y4 receptor forms high-order oligomeric complexes detectable by Blue Native gel electrophoresis. Dimeric P2Y4 selectively partitions into lipid rafts in synaptosomes. UTP stimulation does not shift P2Y4 oligomerization state (in contrast to P2Y6). In naive PC12 cells, endogenous P2Y4 forms hetero-oligomers selectively with P2Y6 (not with P2Y1, P2Y2, or P2Y11).\",\n      \"method\": \"Blue Native gel electrophoresis; co-immunoprecipitation; lipid raft fractionation from synaptosomes; co-transfection studies\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — BN-PAGE and co-immunoprecipitation with subcellular fractionation; orthogonal methods; single lab\",\n      \"pmids\": [\"17481575\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ATP stimulates excitability of guinea pig gallbladder smooth muscle via P2Y4 receptors (RT-PCR confirmed P2Y4 but not P2Y2 expression in muscularis). This excitation requires COX-1 activity (blocked by indomethacin and SC-560) but not COX-2, indicating P2Y4 stimulates prostanoid production via COX-1 to increase smooth muscle excitability.\",\n      \"method\": \"Intracellular recording (membrane potential and action potential frequency); RT-PCR; pharmacological inhibitors (suramin, PPADS, indomethacin, SC-560, nimesulide)\",\n      \"journal\": \"American journal of physiology. Gastrointestinal and liver physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — electrophysiology combined with molecular identification and pharmacological pathway dissection; single lab\",\n      \"pmids\": [\"18436624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"ATP modulates ERK1/2, p38, and JNK1 MAPKs and transcription factors (ATF-1, c-Fos, c-Jun, Jun D) via P2Y2 and P2Y4 receptors in MCF-7 breast cancer cells through a PKC-dependent (not Src-dependent) pathway for MAPK activation. PKC and Src both contribute to c-Fos induction and ATF-1 phosphorylation.\",\n      \"method\": \"RT-PCR receptor identification; specific kinase inhibitors; Src antisense oligonucleotides; Western blot for phospho-MAPKs and transcription factors\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — pharmacological inhibitors without receptor-specific knockdown; cannot fully separate P2Y2 from P2Y4 contribution; single lab\",\n      \"pmids\": [\"19900397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"P2Y4 receptor at the apical membrane of Reissner's membrane epithelium mediates UTP-induced inhibition of amiloride-sensitive Na+ absorption (ENaC) via PLC activation and reduction of plasma membrane PIP2 (not through PKC or store-operated channels). PLC inhibitors markedly reduced the effect; the P2Y4 subtype identity was confirmed by suramin/PPADS insensitivity and RB-2 sensitivity.\",\n      \"method\": \"Voltage-sensitive vibrating probe; amiloride short-circuit current; PLC inhibitors (U73122, ET-18-OCH3); PKC modulators; 2-APB; immunohistochemistry\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct electrophysiology with pharmacological pathway dissection in native epithelium; multiple inhibitors tested; single lab\",\n      \"pmids\": [\"20220010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"P2Y4 receptor is expressed in cardiac endothelial cells but not cardiomyocytes. P2Y4-null mice display microcardia due to reduced endothelial cell proliferation, migration, and PDGF-B secretion in response to UTP. Microvessel and cardiomyocyte proliferation is reduced early postnatally in P2Y4-null hearts, establishing P2Y4 as a regulator of postnatal cardiac growth through endothelial-cardiomyocyte interactions.\",\n      \"method\": \"P2Y4-null mice; cardiac endothelial cell isolation; proliferation and migration assays; PDGF-B secretion measurement; histological quantitation of cardiomyocyte and microvessel density\",\n      \"journal\": \"Angiogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with multiple cellular functional assays; single lab; endothelial-cardiomyocyte interaction mechanism proposed and supported\",\n      \"pmids\": [\"22437266\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Apical targeting of P2Y4 receptor to the apical membrane of polarized epithelial cells is directed by a 23 amino acid sequence in the C-terminal cytoplasmic tail. Four hydrophobic residues near the COOH-terminal end are necessary for apical sorting; mutation of these residues results in basolateral enrichment. The signal is autonomous: it can redirect the normally basolateral P2Y12 receptor to the apical membrane.\",\n      \"method\": \"Mutagenesis (truncation and point mutations); confocal immunofluorescence in polarized MDCK/Caco-2 cells; chimeric P2Y4/P2Y12 receptor constructs\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic mutagenesis with functional localization readout; autonomous signal demonstrated by domain transfer to heterologous receptor; multiple constructs\",\n      \"pmids\": [\"23054062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"P2Y4 receptor mediates ATP-triggered pinocytosis in microglia via the PI3K/Akt signaling cascade. siRNA knockdown of P2Y4 reduced nucleotide-induced pinocytosis. Soluble amyloid-beta 1-42 induced self-uptake in microglia through pinocytosis involving autocrine ATP signaling activating P2Y4 receptors.\",\n      \"method\": \"P2Y4 siRNA knockdown; pharmacological analysis; PI3K/Akt inhibitors; fluorescence-based pinocytosis assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown plus pharmacological pathway dissection with functional readout; single lab\",\n      \"pmids\": [\"24001770\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"P2Y4-null mice display smaller myocardial infarcts, reduced neutrophil infiltration, and reduced fibrosis after LAD ligation. Gene profiling identified endothelin-1 (ET-1) as a target gene of P2Y4 in ischemic heart. Loss of P2Y4 is correlated with reduced endothelial cell number, reduced ET-1, reduced MMP-9 and MMP-8 expression, and reduced microvascular hyperpermeability and endothelial adhesion molecule expression.\",\n      \"method\": \"P2Y4-null mice; LAD ligation model; gene expression profiling; immunohistochemistry for neutrophils; ET-1 measurement; MMP/TIMP expression analysis; LPS-induced inflammation model\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with multiple functional and molecular readouts; ET-1 as mechanistic link supported by correlative evidence; single lab\",\n      \"pmids\": [\"25595790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"P2Y4 receptor expressed in cardiac adipose-derived stem cells acts as a negative regulator of adipogenic differentiation and cardiac fat formation. UTP (P2Y4 ligand) inhibited maturation of differentiated cardiac ASCs and reduced adipogenesis-linked gene expression and adiponectin secretion. P2Y4-null mice had higher cardiac adipose tissue mass and higher adiponectin secretion. Cardioprotection from P2Y4 loss was absent in P2Y4/adiponectin double-KO mice, placing adiponectin downstream of P2Y4 in this pathway.\",\n      \"method\": \"P2Y4-null mice; adipogenic differentiation assays; gene expression (RT-PCR); adiponectin secretion measurement; double-KO epistasis (P2Y4 x adiponectin); LAD ligation\",\n      \"journal\": \"Stem cells and development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis (double KO) and functional differentiation assays; adiponectin placed downstream; single lab\",\n      \"pmids\": [\"27855539\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"P2Y4 receptor in neural precursors promotes specification of glutamatergic neuron identity. Transient P2Y4 activation during ESC neuronal differentiation increased proportion of neurons expressing vGluT (glutamatergic marker). A subpopulation of adult hippocampal type 2 NSCs expresses P2Y4; its activation induced vGluT and TBR1 expression in descendant neurons. Inhibition of P2Y4 signaling abolished these effects.\",\n      \"method\": \"Mouse ESC differentiation assay; P2Y4 pharmacological activation/inhibition; immunostaining for vGluT and TBR1; adult hippocampal NSC analysis\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological gain- and loss-of-function in both ESC and adult NSC systems; single lab\",\n      \"pmids\": [\"26972684\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HIV-1 Tat protein increases P2Y4 receptor expression in astrocytes. P2Y4 signaling mediates Tat-induced proinflammatory cytokine production via PI3K/Akt and ERK1/2-dependent pathways. siRNA knockdown of P2Y4 reduced cytokine production and relieved Tat-mediated neuronal apoptosis in vitro. In vivo Tat challenge in P2Y4 knockdown mice showed decreased hippocampal inflammation and neuronal damage.\",\n      \"method\": \"siRNA knockdown; real-time PCR; Western blot; cytometric bead array; TUNEL/MTT assays; in vivo P2Y4 knockdown mouse model; PI3K/Akt/ERK pathway inhibitors\",\n      \"journal\": \"Journal of neuroinflammation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA KD in vitro and in vivo with pathway inhibitors; multiple orthogonal functional readouts; single lab\",\n      \"pmids\": [\"30947729\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Mutagenesis combined with homology modeling showed that the orthosteric binding site of P2Y4 receptor is more restricted than that of P2Y2. Mutation of Y197 to alanine in P2Y4 receptor conferred gain of ATP sensitivity, identifying this residue as a key determinant of ATP selectivity. Anthraquinone antagonists likely bind orthosteric or allosteric sites depending on their substitution pattern.\",\n      \"method\": \"Site-directed mutagenesis; receptor homology modeling; docking studies; functional Ca2+ assay in transfected 1321N1 cells\",\n      \"journal\": \"Biochimica et biophysica acta. General subjects\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis with functional validation and computational modeling; single lab; functional gain-of-function confirms computational prediction\",\n      \"pmids\": [\"31812541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"P2Y4-null mice display anti-inflammatory pericardial adipose tissue changes after myocardial infarction, including adipocyte beiging with increased PD-L1 expression, higher regulatory M2c macrophages and Treg cells. Injection of anti-PD-L1 blocking antibody abolished the reduction in T cell infiltration and cardiac fibrosis in P2Y4-null ischemic mice, placing PD-L1 downstream of P2Y4 loss in cardioprotection.\",\n      \"method\": \"P2Y4-null mice; LAD ligation; flow cytometry (M2c macrophages, Tregs); anti-PD-L1 antibody blockade epistasis; PD-L1 expression assay\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with antibody-blocking epistasis establishes PD-L1 as downstream effector; single lab\",\n      \"pmids\": [\"36248854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The N178T variant (rs3745601, second extracellular loop) of human P2Y4 is a loss-of-function mutation. P2Y4-null mice showed improved glucose tolerance and insulin sensitivity; this improvement was absent in P2Y4/adiponectin double-KO mice, placing adiponectin downstream of P2Y4 in glucose homeostasis regulation.\",\n      \"method\": \"Functional Ca2+ assay of N178T variant in transfected cells; P2Y4-null mice glucose tolerance test and insulin sensitivity test; P2Y4/adiponectin double-KO mice\",\n      \"journal\": \"Frontiers in pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — functional variant characterization combined with double-KO epistasis; single lab; genetic epistasis supports mechanism\",\n      \"pmids\": [\"36532779\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"P2Y4-null ischemic mice show increased plasma PD-L1+ exosomes and adiponectin-associated exosomes from adipocyte origin. Inhibition of exosome release (GW4869) abolished the reduction in cardiac fibrosis and T cell infiltration observed in P2Y4-null mice and prevented plasma PD-L1 increase. P2Y4-null pericardial adipose tissue showed increased CDH13/T-cadherin expression (required for adiponectin-driven exosome biogenesis). Exosomes from P2Y4-null ischemic mice polarized macrophages to anti-inflammatory M2c phenotype in vitro.\",\n      \"method\": \"P2Y4-null mice; GW4869 exosome inhibitor treatment epistasis; nanoparticle tracking analysis; TEM; Western blot (CD63, adiponectin); flow cytometry (PD-L1+ exosomes); in vitro macrophage polarization assay\",\n      \"journal\": \"Frontiers in pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological epistasis with exosome inhibitor plus multiple orthogonal characterization methods; single lab\",\n      \"pmids\": [\"41164751\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"P2Y4 is a Gq-coupled (and conditionally Gi/o-coupled) GPCR activated primarily by UTP (and in rodents also ATP), which signals through PLC/IP3/Ca2+, RhoA/Rho kinase, PI3K/Akt, and MAPK pathways; its activity is terminated by agonist-driven phosphorylation of Ser-333/Ser-334 leading to desensitization and internalization, it is sorted to the apical membrane of polarized epithelia via a hydrophobic C-terminal targeting signal, forms homo- and hetero-oligomers, couples to M-type K+ and N-type Ca2+ channels in neurons, and in vivo regulates epithelial ion transport (Cl−, K+, Na+), cardiac angiogenesis and postnatal development, glucose homeostasis via adiponectin, and post-ischemic cardiac inflammation via the ET-1/PD-L1/exosome axis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"P2RY4 (P2Y4) is a pyrimidinergic G-protein-coupled receptor that couples to phospholipase C to generate inositol trisphosphate and mobilize intracellular Ca2+ in response to extracellular nucleotides [#0]. UTP is the primary full agonist of the human receptor, where ATP behaves as a competitive antagonist, whereas the rodent orthologs are activated equipotently by UTP and ATP — a species difference traced to residues in the second extracellular loop and N-terminus (including Asn-177/Y197) that govern ATP agonism versus antagonism [#5, #12, #32]. The receptor is pharmacologically distinguished from other P2Y subtypes by its insensitivity to suramin and PPADS [#2, #3]. Beyond Gq/PLC, P2Y4 engages Gi/o (pertussis-toxin-sensitive) coupling, RhoA/Rho-kinase-driven actin remodeling, PI3K/Akt, and ERK/p38/JNK MAPK cascades that drive proliferation and immediate-early/AP-1 transcription [#0, #6, #16, #27]. Signaling is terminated by agonist-promoted phosphorylation of carboxy-terminal Ser-333/Ser-334, which mediates desensitization and internalization [#7], and the receptor is delivered to the apical membrane of polarized epithelia by an autonomous hydrophobic 23-residue C-terminal sorting signal [#26]. P2Y4 assembles into homo-oligomers and selective hetero-oligomers with P2Y6, and co-localizes with NMDAR1 [#14, #21, #15]. Functionally, it couples to M-type K+ and N-type Ca2+ channels and to Ca2+-activated K+ channels in neurons and heterologous systems [#13, #20], and is required in vivo for nucleotide-regulated epithelial Cl-, K+, and Na+ transport [#11, #17, #19, #24]. P2Y4-null mice further reveal roles in postnatal cardiac growth via endothelial PDGF-B signaling [#25], in post-ischemic cardiac inflammation through an ET-1/PD-L1/exosome and adiponectin axis [#28, #33, #35], and in glucose homeostasis, where the human loss-of-function N178T variant and adiponectin-dependent epistasis link the receptor to insulin sensitivity [#34, #29].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established the molecular identity and signaling output of P2Y4 — that the cloned receptor is a UTP-preferring pyrimidinergic GPCR coupling to PLC, resolving its place among purinoceptors.\",\n      \"evidence\": \"Genomic cloning, tissue Northern/RT-PCR, and stable expression in 1321N1 cells with IP accumulation and pertussis toxin block\",\n      \"pmids\": [\"8997625\", \"8617367\", \"8968535\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dual Gq/Gi coupling inferred from PTX block only, no direct G-protein reconstitution\", \"Endogenous tissue function not addressed\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined a species-specific pharmacology — rodent P2Y4 is activated equipotently by ATP and UTP while human P2Y4 is not — a distinction critical for interpreting all cross-species functional studies.\",\n      \"evidence\": \"Rat genomic cloning and pharmacological characterization in transfected and native aortic smooth muscle cells, with MAPK and proliferation readouts\",\n      \"pmids\": [\"9647463\", \"9751165\", \"9690862\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of species difference not yet localized\", \"Physiological relevance of smooth-muscle proliferation untested in vivo\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Quantified the ATP antagonism at human P2Y4 and identified Ser-333/Ser-334 phosphorylation as the desensitization/internalization switch, defining how receptor activity is terminated.\",\n      \"evidence\": \"Schild analysis of Ca2+ responses in 1321N1 cells; truncation/point mutagenesis with 32P radiolabeling and surface receptor quantitation; RhoA dominant-negative and C3 exoenzyme assays\",\n      \"pmids\": [\"10779375\", \"11114308\", \"10843869\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase responsible for Ser-333/334 phosphorylation not identified\", \"Arrestin/clathrin machinery of internalization not defined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Localized the determinants of ATP agonism to EL2/N-terminus and showed P2Y4 controls neuronal ion channels, linking receptor structure to effector coupling.\",\n      \"evidence\": \"Human/rat chimeric and point mutagenesis with Ca2+ assays; electrophysiological reconstitution in rat sympathetic neurons with PTX and transducin Gα\",\n      \"pmids\": [\"14670966\", \"12540532\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full orthosteric pocket structure not resolved\", \"Endogenous neuronal agonist source unaddressed\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrated that P2Y4 self-assembles into disulfide-linked homo-oligomers, raising the question of oligomerization-dependent function.\",\n      \"evidence\": \"Differential co-immunoprecipitation of tagged constructs; reducing/non-reducing SDS-PAGE\",\n      \"pmids\": [\"18404459\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of oligomerization not established\", \"Single lab\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Genetic knockout established P2Y4 as the essential receptor for nucleotide-regulated epithelial Cl- and K+ transport in intestine, moving from heterologous pharmacology to physiological necessity.\",\n      \"evidence\": \"P2Y4-null, P2Y2-null, and double-KO mice with Ussing-chamber short-circuit current; Xenopus oocyte co-expression with BK/IK channels\",\n      \"pmids\": [\"12644577\", \"15718265\", \"16056234\", \"16075244\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Coupling between receptor and specific channels in native epithelium correlative\", \"Apical channel identity in vivo not fully resolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Showed P2Y4 drives neuronal differentiation and immediate-early/AP-1 transcription, extending its role beyond ion transport into developmental gene programs.\",\n      \"evidence\": \"Transfection of SH-SY5Y cells with UTP stimulation; morphology, NFL immunostaining, RT-PCR for cdk-5/NeuroD6, AP-1 reporters\",\n      \"pmids\": [\"15649700\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Performed in overexpression system\", \"Endogenous neuronal contribution not isolated\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Refined oligomerization biology by showing endogenous P2Y4 forms selective P2Y6 hetero-oligomers and partitions into lipid rafts in native neurons.\",\n      \"evidence\": \"Blue Native PAGE, co-IP, and lipid raft fractionation from synaptosomes and PC12 cells\",\n      \"pmids\": [\"17481575\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Signaling output of P2Y4/P2Y6 heteromers not determined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined the apical-sorting signal and established a developmental cardiac function, connecting receptor trafficking and endothelial signaling to postnatal heart growth.\",\n      \"evidence\": \"Mutagenesis/chimera localization in polarized MDCK/Caco-2 cells; P2Y4-null mice with endothelial proliferation, migration, and PDGF-B assays\",\n      \"pmids\": [\"23054062\", \"22437266\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Trafficking machinery recognizing the hydrophobic signal unidentified\", \"Endothelial-cardiomyocyte crosstalk mechanism correlative\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showed P2Y4 drives microglial pinocytosis via PI3K/Akt, implicating it in nucleotide-driven uptake including amyloid-beta.\",\n      \"evidence\": \"siRNA knockdown and PI3K/Akt inhibitors with fluorescence pinocytosis assay\",\n      \"pmids\": [\"24001770\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct receptor-to-PI3K coupling not biochemically mapped\", \"In vivo relevance untested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Placed adiponectin downstream of P2Y4 in cardiac adipogenesis and identified a role in glutamatergic neuron specification, broadening the receptor's developmental and metabolic reach.\",\n      \"evidence\": \"P2Y4-null and P2Y4/adiponectin double-KO epistasis with adipogenic and adiponectin assays; ESC/NSC differentiation with P2Y4 pharmacology and vGluT/TBR1 staining\",\n      \"pmids\": [\"27855539\", \"26972684\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking receptor to adiponectin transcription unresolved\", \"Neuronal specification shown pharmacologically, no genetic NSC deletion\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Implicated P2Y4 in neuroinflammation, showing HIV-1 Tat upregulates the receptor and P2Y4 signaling drives cytokine production via PI3K/Akt and ERK.\",\n      \"evidence\": \"siRNA knockdown in vitro and in vivo, pathway inhibitors, cytokine and apoptosis readouts\",\n      \"pmids\": [\"30947729\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct receptor-Tat relationship not biochemically defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Mapped the cardioprotective consequences of P2Y4 loss to PD-L1- and adiponectin-dependent anti-inflammatory pathways, and characterized a human loss-of-function variant linking the receptor to glucose homeostasis.\",\n      \"evidence\": \"P2Y4-null mice with LAD ligation, flow cytometry, anti-PD-L1 blockade epistasis; N178T variant Ca2+ assay and P2Y4/adiponectin double-KO glucose tolerance tests\",\n      \"pmids\": [\"36248854\", \"36532779\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"PD-L1 and adiponectin placed downstream by epistasis but direct transcriptional control not shown\", \"Human variant phenotype based on rodent mechanism\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Integrated the cardioprotection axis into an exosome-mediated mechanism, showing PD-L1+ and adiponectin-associated exosomes from P2Y4-null adipose tissue polarize macrophages and reduce fibrosis.\",\n      \"evidence\": \"P2Y4-null mice with GW4869 exosome-inhibitor epistasis, nanoparticle tracking, TEM, CDH13 Western blot, in vitro macrophage polarization\",\n      \"pmids\": [\"41164751\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal chain from receptor to exosome biogenesis correlative\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How agonist binding is structurally transduced to selective G-protein, channel, and oligomer-dependent outputs, and whether the ET-1/PD-L1/adiponectin/exosome cardiac axis operates in humans, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No experimental receptor structure\", \"Human in vivo cardiac/metabolic mechanism rests on rodent KO inference\", \"Kinase and trafficking machinery for desensitization and apical sorting unidentified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 5, 13]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [13, 20, 24]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [7, 10, 26]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 6, 13]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [11, 17, 19, 24]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [28, 33, 35]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"P2RY6\", \"GRIN1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}